Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Andrade, BB"" wg kryterium: Autor


Tytuł:
Isoniazid Monoresistance and Antituberculosis Treatment Outcome in Persons With Pulmonary Tuberculosis in Brazil.
Autorzy:
Araújo-Pereira M; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.; Instituto de Pesquisa Clínica e Translacional, Curso de Medicina, Curso Universitário Faculdades de Tecnologias e Ciência, Salvador, Brazil.
Arriaga MB; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Carvalho ACC; Programa Acadêmico de Tuberculose da Faculdade de Medicina, Complexo hospitalar Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Laboratório de Inovações em Terapias, Ensino e Bioprodutos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Spener-Gomes R; Instituto de Pesquisa Clínica Carlos Borborema, Fundação Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.; Faculdade de Medicina, Universidade Federal do Amazonas, Manaus, Brazil.
Schmaltz CAS; Laboratório de Pesquisa Clínica em Micobacteriose, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Nogueira BMF; Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.; Instituto de Pesquisa Clínica e Translacional, Curso de Medicina, Curso Universitário Faculdades de Tecnologias e Ciência, Salvador, Brazil.
Figueiredo MC; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Turner MM; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Cordeiro-Santos M; Instituto de Pesquisa Clínica Carlos Borborema, Fundação Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.; Faculdade de Medicina, Universidade Nilton Lins, Manaus, Brazil.
Rolla VC; Laboratório de Pesquisa Clínica em Micobacteriose, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Sterling TR; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Andrade BB; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.; Instituto de Pesquisa Clínica e Translacional, Curso de Medicina, Curso Universitário Faculdades de Tecnologias e Ciência, Salvador, Brazil.
Kritski AL; Programa Acadêmico de Tuberculose da Faculdade de Medicina, Complexo hospitalar Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Pokaż więcej
Corporate Authors:
Regional Prospective Observational Research for Tuberculosis (RePORT)-Brazil Consortium
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 08; Vol. 11 (1), pp. ofad691. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction.
Autorzy:
Queiroz ATL; Centro de Integração de Dados e Conhecimentos para Saúde, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810‑710, Brazil.
Vinhaes CL; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810‑710, Brazil.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, 40290-150, Brazil.
Fukutani ER; Centro de Integração de Dados e Conhecimentos para Saúde, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Gupte AN; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Kumar NP; National Institutes of Health- NIRT - International Center for Excellence in Research, Chennai, India.
Fukutani KF; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Arriaga MB; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810‑710, Brazil.
Sterling TR; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Babu S; National Institutes of Health- NIRT - International Center for Excellence in Research, Chennai, India.
Gaikwad S; Department of Pulmonary Medicine, Byramjee-Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India.
Karyakarte R; Department of Microbiology, Byramjee-Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India.
Mave V; Byramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.; Johns Hopkins Center for Infectious Diseases in India, Pune, India.
Paradhkar M; Byramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.; Johns Hopkins Center for Infectious Diseases in India, Pune, India.
Viswanathan V; Prof. M. Viswanathan Diabetes Research Centre, Chennai, India.
Gupta A; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Andrade BB; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil. bruno.andrade@fiocruz.br.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810‑710, Brazil. bruno.andrade@fiocruz.br.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, 40290-150, Brazil. bruno.andrade@fiocruz.br.; Faculdade de Tecnologia e Ciências, Instituto de Pesquisa Clínica e Translacional, Salvador, 41741-590, Brazil. bruno.andrade@fiocruz.br.
Kornfeld H; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA. .; UMass Chan Medical School, Worcester, MA, USA. .
Pokaż więcej
Corporate Authors:
RePORT Brazil
RePORT India Consortia
Źródło:
Scientific reports [Sci Rep] 2023 May 12; Vol. 13 (1), pp. 7769. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus*/genetics
Diabetes Mellitus*/metabolism
Tuberculosis*/genetics
Tuberculosis*/complications
Tuberculosis, Pulmonary*/genetics
Tuberculosis, Pulmonary*/complications
Adult ; Humans ; Prospective Studies ; Gene Expression
Czasopismo naukowe
Tytuł:
Dissecting disease tolerance in Plasmodium vivax malaria using the systemic degree of inflammatory perturbation.
Autorzy:
Vinhaes CL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Brazil.
Carmo TA; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Curso de Medicina, Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Brazil.
Queiroz ATL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.
Fukutani KF; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Curso de Medicina, Centro Universitário Facultade de Tecnologia e Ciências (UniFTC), Salvador, Brazil.
Araújo-Pereira M; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Faculdade de Medicina, Salvador, Brazil.
Arriaga MB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Faculdade de Medicina, Salvador, Brazil.
Lacerda MVG; Instituto de Pesquisa Clínica Carlos Borborema, Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.; Instituto Leônidas & Maria Deane, Fundação Oswaldo Cruz, Manaus, Brazil.
Barral-Netto M; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Faculdade de Medicina, Salvador, Brazil.; Instituto Nacional de Ciência e Tecnologia, Instituto de Investigação em Imunologia, São Paulo, Brazil.
Andrade BB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Brazil.; Curso de Medicina, Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Brazil.; Curso de Medicina, Centro Universitário Facultade de Tecnologia e Ciências (UniFTC), Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Faculdade de Medicina, Salvador, Brazil.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2021 Nov 02; Vol. 15 (11), pp. e0009886. Date of Electronic Publication: 2021 Nov 02 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Malaria, Vivax/*immunology
Plasmodium vivax/*physiology
Adult ; Brazil ; Female ; Humans ; Interleukin-1beta/genetics ; Interleukin-1beta/immunology ; Interleukin-4/genetics ; Interleukin-4/immunology ; Malaria, Vivax/genetics ; Malaria, Vivax/parasitology ; Male ; Middle Aged ; Plasmodium vivax/genetics ; Retrospective Studies ; Severity of Illness Index ; Young Adult
Czasopismo naukowe
Tytuł:
The influence of single nucleotide polymorphisms of NOD2 or CD14 on the risk of Mycobacterium tuberculosis diseases: a systematic review.
Autorzy:
Cubillos-Angulo JM; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.
Fernandes CD; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.; Curso de Medicina, Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Bahia, Brazil.
Araújo DN; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.
Carmo CA; Curso de Medicina, Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Bahia, Brazil.
Arriaga MB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.
Andrade BB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil. bruno.andrade@fiocruz.br.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil. bruno.andrade@fiocruz.br.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil. bruno.andrade@fiocruz.br.; Curso de Medicina, Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Bahia, Brazil. bruno.andrade@fiocruz.br.; Curso de Medicina, Faculdade de Tecnologia e Ciências (FTC), Salvador, Bahia, Brazil. bruno.andrade@fiocruz.br.; Curso de Medicina, Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil. bruno.andrade@fiocruz.br.; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. bruno.andrade@fiocruz.br.; Wellcome Centre for Infectious Disease Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. bruno.andrade@fiocruz.br.
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2021 Jun 09; Vol. 10 (1), pp. 174. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Polymorphism, Single Nucleotide*
Alleles ; Case-Control Studies ; Genetic Predisposition to Disease/genetics ; Genotype ; Humans ; Nod2 Signaling Adaptor Protein/genetics
Czasopismo naukowe
Tytuł:
Zika-exposed microcephalic neonates exhibit higher degree of inflammatory imbalance in cerebrospinal fluid.
Autorzy:
Nascimento-Carvalho GC; Bahiana Foundation for Science Development, Bahiana School of Medicine, Salvador, Bahia, 40290-000, Brazil. .
Nascimento-Carvalho EC; Bahiana Foundation for Science Development, Bahiana School of Medicine, Salvador, Bahia, 40290-000, Brazil.
Ramos CL; Bahiana Foundation for Science Development, Bahiana School of Medicine, Salvador, Bahia, 40290-000, Brazil.
Vilas-Boas AL; Bahiana Foundation for Science Development, Bahiana School of Medicine, Salvador, Bahia, 40290-000, Brazil.
Moreno-Carvalho OA; Cerebrospinal Fluid Laboratory, José Silveira Foundation, Salvador, Bahia, 40170-100, Brazil.
Vinhaes CL; Bahiana Foundation for Science Development, Bahiana School of Medicine, Salvador, Bahia, 40290-000, Brazil.; Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, 40296-710, Brazil.
Barreto-Duarte B; Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, 40296-710, Brazil.; University Salvador (UNIFACS), Laureate Universities, Salvador, Bahia, 41820-021, Brazil.
Queiroz ATL; Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, 40296-710, Brazil.
Andrade BB; Bahiana Foundation for Science Development, Bahiana School of Medicine, Salvador, Bahia, 40290-000, Brazil.; Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, 40296-710, Brazil.; University Salvador (UNIFACS), Laureate Universities, Salvador, Bahia, 41820-021, Brazil.; School of Medicine, Faculdade de Tecnologia e Ciências (Uni-FTC), Salvador, Bahia, 41741-590, Brazil.; Wellcome Centre for Infectious Disease Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7700, South Africa.; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Nascimento-Carvalho CM; Department of Pediatrics, Federal University of Bahia School of Medicine, Salvador, Bahia, 40210-630, Brazil.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 19; Vol. 11 (1), pp. 8474. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers/*cerebrospinal fluid
Inflammation Mediators/*cerebrospinal fluid
Microcephaly/*pathology
Pregnancy Complications, Infectious/*pathology
Zika Virus/*isolation & purification
Zika Virus Infection/*complications
Brazil/epidemiology ; Case-Control Studies ; Female ; Follow-Up Studies ; Humans ; Infant, Newborn ; Male ; Microcephaly/cerebrospinal fluid ; Microcephaly/epidemiology ; Microcephaly/etiology ; Pregnancy ; Pregnancy Complications, Infectious/cerebrospinal fluid ; Pregnancy Complications, Infectious/epidemiology ; Pregnancy Complications, Infectious/etiology ; Prognosis ; Prospective Studies ; Retrospective Studies ; Zika Virus Infection/virology
Czasopismo naukowe
Tytuł:
Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV.
Autorzy:
Vinhaes CL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 40210-320, Brazil.; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador 40290-000, Brazil.
Araujo-Pereira M; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 40210-320, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.
Tibúrcio R; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 40210-320, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.
Cubillos-Angulo JM; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 40210-320, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.
Demitto FO; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 40210-320, Brazil.
Akrami KM; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 40210-320, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.; Divisions of Infectious Diseases and Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, CA 92093, USA.
Andrade BB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 40210-320, Brazil.; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador 40290-000, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.; Curso de Medicina, Centro Universitário Faculdade de Tecnologia e Ciências (UniFTC), Salvador 41741-590, Brazil.
Pokaż więcej
Źródło:
Life (Basel, Switzerland) [Life (Basel)] 2021 Jan 18; Vol. 11 (1). Date of Electronic Publication: 2021 Jan 18.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Association between neurofibromatosis type 1 and cerebrovascular diseases in children: A systematic review.
Autorzy:
Barreto-Duarte B; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.; Curso de Medicina, Universidade Salvador (UNIFACS), Salvador, Bahia, Brazil.; Programa de Pós-Graduação em Clínica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Andrade-Gomes FH; Curso de Medicina, Universidade Salvador (UNIFACS), Salvador, Bahia, Brazil.
Arriaga MB; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.; Curso de Medicina, Centro Universitário Faculdade de Tecnologia e Ciências (UniFTC), Salvador, Bahia, Brazil.
Araújo-Pereira M; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil.
Cubillos-Angulo JM; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.; Curso de Medicina, Centro Universitário Faculdade de Tecnologia e Ciências (UniFTC), Salvador, Bahia, Brazil.
Andrade BB; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil.; Curso de Medicina, Universidade Salvador (UNIFACS), Salvador, Bahia, Brazil.; Programa de Pós-Graduação em Clínica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Curso de Medicina, Centro Universitário Faculdade de Tecnologia e Ciências (UniFTC), Salvador, Bahia, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil.; Curso de Medicina, Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Bahia, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jan 04; Vol. 16 (1), pp. e0241096. Date of Electronic Publication: 2021 Jan 04 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Cerebrovascular Disorders*/diagnosis
Cerebrovascular Disorders*/metabolism
Cerebrovascular Disorders*/therapy
Neurofibromatosis 1*/diagnosis
Neurofibromatosis 1*/metabolism
Neurofibromatosis 1*/therapy
Adolescent ; Child ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł:
Integration of metabolomics and transcriptomics reveals novel biomarkers in the blood for tuberculosis diagnosis in children.
Autorzy:
Dutta NK; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, 1551 East Jefferson Street, Room 110, Baltimore, MD, 21287, USA. .
Tornheim JA; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, 1551 East Jefferson Street, Room 110, Baltimore, MD, 21287, USA.; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Fukutani KF; Laboratório de Inflamação E Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia E Ciências, Salvador, Brazil.
Paradkar M; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Tiburcio RT; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia E Ciências, Salvador, Brazil.
Kinikar A; Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Valvi C; Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Kulkarni V; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Pradhan N; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Shivakumar SVBY; Johns Hopkins University - India Office (CCGHE), Pune, Maharashtra, India.
Kagal A; Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Gupte A; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gupte N; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Mave V; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Gupta A; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, 1551 East Jefferson Street, Room 110, Baltimore, MD, 21287, USA.; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Andrade BB; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia E Ciências, Salvador, Brazil.; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.; Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Brazil.; Escola Bahiana de Medicina E Saúde Pública (EBMSP), Salvador, Brazil.
Karakousis PC; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, 1551 East Jefferson Street, Room 110, Baltimore, MD, 21287, USA. .; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Nov 11; Vol. 10 (1), pp. 19527. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji:
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers/*blood
Tuberculosis/*blood
Tuberculosis/*diagnosis
Tuberculosis/*drug therapy
Adolescent ; Antitubercular Agents/therapeutic use ; Case-Control Studies ; Child ; Chromatography, Liquid ; Family Characteristics ; Female ; Gene Expression Profiling ; Humans ; Longitudinal Studies ; Male ; Mass Spectrometry/methods ; Metabolomics/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Are prognostic tools losing accuracy? Development and performance of a novel age-calibrated severity scoring system for critically ill patients.
Autorzy:
Menezes RC; Hospital de Cidade, Núcleo de Pesquisa, Ensino e Comunicação, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.; Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Ferreira IBB; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Universidade do Estado da Bahia (UNEB), Salvador, Bahia, Brazil.
Carmo TA; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Universidade Salvador (UNIFACS), Salvador, Bahia, Brazil.
Telles GP; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Bahia, Brazil.
Pugas PLD; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Bahia, Brazil.
Otero ML; Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Arriaga MB; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.; Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Fukutani KF; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.
Neto LP; Hospital de Cidade, Intensive Care Unit, Salvador, Bahia, Brazil.
Agareno S; Hospital de Cidade, Intensive Care Unit, Salvador, Bahia, Brazil.
Filgueiras Filho NM; Hospital de Cidade, Núcleo de Pesquisa, Ensino e Comunicação, Salvador, Brazil.; Universidade do Estado da Bahia (UNEB), Salvador, Bahia, Brazil.; Universidade Salvador (UNIFACS), Salvador, Bahia, Brazil.
Akrami KM; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.; Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.; Division of Infectious Diseases and Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, California, United States of America.
Andrade BB; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.; Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.; Universidade Salvador (UNIFACS), Salvador, Bahia, Brazil.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Bahia, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Nov 04; Vol. 15 (11), pp. e0240793. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hospital Mortality*
Critical Illness/*therapy
Hospitalization/*statistics & numerical data
Intensive Care Units/*statistics & numerical data
Aged ; Aged, 80 and over ; Brazil ; Calibration ; Cohort Studies ; Critical Illness/classification ; Critical Illness/mortality ; Female ; Humans ; Intensive Care Units/standards ; Logistic Models ; Male ; Middle Aged ; Prognosis ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia.
Autorzy:
Vinhaes CL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.; School of Medicine, Faculdade de Tecnologia E Ciências (UniFTC), Salvador, 41741-590, Brazil.
Teixeira RS; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador, 40290-000, Brazil.; School of Medicine, Federal University of Bahia, Salvador, 40110-100, Brazil.
Monteiro-Júnior JAS; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador, 40290-000, Brazil.
Tibúrcio R; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.; School of Medicine, Federal University of Bahia, Salvador, 40110-100, Brazil.
Cubillos-Angulo JM; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.; School of Medicine, Federal University of Bahia, Salvador, 40110-100, Brazil.
Arriaga MB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.; School of Medicine, Federal University of Bahia, Salvador, 40110-100, Brazil.
Sabarin AG; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador, 40290-000, Brazil.
de Souza AJ; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador, 40290-000, Brazil.
Silva JJ; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, 40296-710, Brazil.; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador, 40290-000, Brazil.
Lyra IM; University Salvador (UNIFACS), Laureate International Universities, Salvador, 41720-200, Brazil.
Ladeia AM; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador, 40290-000, Brazil.; Catholic University of Salvador, Salvador, 41740-090, Brazil.
Andrade BB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, 40296-710, Brazil. bruno.andrade@fiocruz.br.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil. bruno.andrade@fiocruz.br.; School of Medicine, Faculdade de Tecnologia E Ciências (UniFTC), Salvador, 41741-590, Brazil. bruno.andrade@fiocruz.br.; Bahiana School of Medicine and Public Health, Bahia Foundation for the Development of Sciences, Salvador, 40290-000, Brazil. bruno.andrade@fiocruz.br.; School of Medicine, Federal University of Bahia, Salvador, 40110-100, Brazil. bruno.andrade@fiocruz.br.; University Salvador (UNIFACS), Laureate International Universities, Salvador, 41720-200, Brazil. bruno.andrade@fiocruz.br.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Nov 04; Vol. 10 (1), pp. 18982. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anemia, Sickle Cell/*drug therapy
Biomarkers/*blood
Hydroxyurea/*administration & dosage
Oxidative Stress/*drug effects
Adolescent ; Anemia, Sickle Cell/blood ; Brazil ; Case-Control Studies ; Child ; Female ; Humans ; Hydroxyurea/pharmacology ; Male ; Principal Component Analysis ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
In silico transcriptional analysis of mRNA and miRNA reveals unique biosignatures that characterizes different types of diabetes.
Autorzy:
Cubillos-Angulo JM; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências (FTC), Salvador, Brazil.
Vinhaes CL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências (FTC), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.
Fukutani ER; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Albuquerque VVS; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Brazil.
Queiroz ATL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.
Andrade BB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências (FTC), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Brazil.; Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Brazil.
Fukutani KF; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências (FTC), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Sep 21; Vol. 15 (9), pp. e0239061. Date of Electronic Publication: 2020 Sep 21 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1/*genetics
Diabetes Mellitus, Type 2/*genetics
MicroRNAs/*genetics
Prediabetic State/*genetics
RNA, Messenger/*genetics
Diabetes Mellitus, Type 1/diagnosis ; Diabetes Mellitus, Type 2/diagnosis ; Gene Expression Profiling ; Gene Regulatory Networks ; Humans ; Prediabetic State/diagnosis
Czasopismo naukowe
Tytuł:
Chronic Hepatitis B Infection Is Associated with Increased Molecular Degree of Inflammatory Perturbation in Peripheral Blood.
Autorzy:
Vinhaes CL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 41810-710, Brazil.; Curso de Medicina, Centro Universitário Faculdade de Tecnologia e Ciências (UniFTC), Salvador 41741-590, Brazil.
Cruz LAB; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 41810-710, Brazil.
Menezes RC; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 41810-710, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.
Carmo TA; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 41810-710, Brazil.; Curso de Medicina, Universidade Salvador (UNIFACS), Laureate Universities, Salvador 41720-200, Brazil.
Arriaga MB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 41810-710, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.
Queiroz ATL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 41810-710, Brazil.
Barral-Netto M; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador 40296-710, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.; Instituto Nacional de Ciencia e Tecnologia de Investigação Em Imunologia, São Paulo 05403-900, Brazil.
Andrade BB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador 41810-710, Brazil.; Curso de Medicina, Centro Universitário Faculdade de Tecnologia e Ciências (UniFTC), Salvador 41741-590, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-100, Brazil.; Curso de Medicina, Universidade Salvador (UNIFACS), Laureate Universities, Salvador 41720-200, Brazil.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador 40290-000, Brazil.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 Aug 07; Vol. 12 (8). Date of Electronic Publication: 2020 Aug 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cytokines/*blood
Hepatitis B, Chronic/*blood
Hepatitis B, Chronic/*immunology
Inflammation/*blood
Inflammation/*virology
Adult ; Biomarkers/blood ; Brazil ; Female ; Humans ; Interferon-gamma/blood ; Interleukin-4/blood ; Male ; Middle Aged ; Retrospective Studies ; Viral Load ; Young Adult
Czasopismo naukowe
Tytuł:
A clinical scoring system to predict long-term arthralgia in Chikungunya disease: A cohort study.
Autorzy:
de Moraes L; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.
Cerqueira-Silva T; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.
Nobrega V; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.
Akrami K; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; University of California, San Diego, Division of Infectious Disease, Department of Medi- cine, San Diego, California, United States of America.
Santos LA; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.
Orge C; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.
Casais P; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.
Cambui L; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.
Rampazzo RCP; Instituto de Biologia Molecular do Paraná, Curitiba, PR, Brasil.
Trinta KS; Fundação Oswaldo Cruz, Bio-Manguinhos, Rio de Janeiro, RJ, Brazil.
Montalbano CA; Faculdade de Medicina, Universidade do Mato Grosso do Sul, Campo Grande- MS, Brazil.
Teixeira MJ; Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza-CE, Brazil.
Cavalcante LP; Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza-CE, Brazil.
Andrade BB; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.
Cunha RVD; Faculdade de Medicina, Universidade do Mato Grosso do Sul, Campo Grande- MS, Brazil.; Fiocruz, Campo Grande, MS, Brazil.
Krieger MA; Instituto de Biologia Molecular do Paraná, Curitiba, PR, Brasil.; Instituto Carlos Chagas-ICC/Fiocruz, Curitiba-PR, Brazil.
Barral-Netto M; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.; Instituto Nacional de Ciência e Tecnologia de Investigação em Imunologia, São Paulo- SP, Brazil.
Barral A; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.; Instituto Nacional de Ciência e Tecnologia de Investigação em Imunologia, São Paulo- SP, Brazil.
Khouri R; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.; Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Boaventura VS; Instituto Gonçalo Moniz (IGM)-Fundação Oswaldo Cruz (Fiocruz) Bahia.; Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador-BA, Brazil.; Serviço de Otorrinolaringologia do Hospital Santa Izabel/Santa Casa de Misericórdia da Bahia (HIS/SCMBa), Salvador, Brazil.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Jul 21; Vol. 14 (7), pp. e0008467. Date of Electronic Publication: 2020 Jul 21 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Arthralgia/*etiology
Chikungunya Fever/*complications
Adult ; Arthralgia/pathology ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Reproducibility of Results ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł:
Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis.
Autorzy:
Oliveira-de-Souza D; Fundação Oswaldo Cruz, Instituto Gonçalo Moniz, Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências (UniFTC), Salvador, 40290-150, Brazil.
Vinhaes CL; Fundação Oswaldo Cruz, Instituto Gonçalo Moniz, Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências (UniFTC), Salvador, 40290-150, Brazil.
Arriaga MB; Fundação Oswaldo Cruz, Instituto Gonçalo Moniz, Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.
Kumar NP; International Center for Excellence in Research, National Institutes of Health- National Institute for Research in Tuberculosis, Chennai, 600031, India.
Queiroz ATL; Fundação Oswaldo Cruz, Instituto Gonçalo Moniz, Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.
Fukutani KF; Fundação Oswaldo Cruz, Instituto Gonçalo Moniz, Salvador, 40296-710, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências (UniFTC), Salvador, 40290-150, Brazil.
Babu S; International Center for Excellence in Research, National Institutes of Health- National Institute for Research in Tuberculosis, Chennai, 600031, India.; Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, 20892, USA.
Andrade BB; Fundação Oswaldo Cruz, Instituto Gonçalo Moniz, Salvador, 40296-710, Brazil. bruno.andrade@fiocruz.br.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, 41810-710, Brazil. bruno.andrade@fiocruz.br.; Curso de Medicina, Faculdade de Tecnologia e Ciências (UniFTC), Salvador, 40290-150, Brazil. bruno.andrade@fiocruz.br.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, 40290-000, Brazil. bruno.andrade@fiocruz.br.; Laureate Universities, Universidade Salvador (UNIFACS), Salvador, 41720-200, Brazil. bruno.andrade@fiocruz.br.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa. bruno.andrade@fiocruz.br.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Jul 09; Vol. 10 (1), pp. 11358. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Aging/*immunology
Cytokines/*blood
Inflammation/*diagnosis
Tuberculosis/*immunology
Adolescent ; Adult ; Age Factors ; Aging/blood ; Biomarkers/blood ; Child ; Child, Preschool ; Cytokines/immunology ; Female ; Humans ; Infant ; Inflammation/blood ; Inflammation/immunology ; Male ; Middle Aged ; Mycobacterium tuberculosis/immunology ; Tuberculosis/blood ; Tuberculosis/microbiology
Czasopismo naukowe
Tytuł:
Differential expression of polyamine biosynthetic pathways in skin lesions and in plasma reveals distinct profiles in diffuse cutaneous leishmaniasis.
Autorzy:
Malta-Santos H; Universidade Federal da Bahia, Salvador, Brazil.; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
França-Costa J; Universidade Federal da Bahia, Salvador, Brazil.; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
Macedo A; Departamento de Botânica, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Queiroz ATL; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
Fukutani KF; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.
Muxel SM; Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Khouri R; Universidade Federal da Bahia, Salvador, Brazil.; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
Van Weyenbergh J; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Boaventura V; Universidade Federal da Bahia, Salvador, Brazil.; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
Barral A; Universidade Federal da Bahia, Salvador, Brazil.; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
Costa JM; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Universidade Federal do Maranhão, São Luis, Brazil.
Floh EIS; Departamento de Botânica, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Andrade BB; Universidade Federal da Bahia, Salvador, Brazil.; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil.; Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Brazil.
Floeter-Winter LM; Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Borges VM; Universidade Federal da Bahia, Salvador, Brazil. .; Instituto Gonçalo Moniz (IGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Jun 29; Vol. 10 (1), pp. 10543. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Amino Acids/*metabolism
Biosynthetic Pathways/*physiology
Leishmaniasis, Diffuse Cutaneous/*metabolism
Polyamines/*metabolism
Skin/*metabolism
Adult ; Amino Acids/blood ; Cross-Sectional Studies ; Female ; Humans ; Male ; Mucous Membrane/metabolism ; Polyamines/blood
Czasopismo naukowe
Tytuł:
Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study).
Autorzy:
Safe IP; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Lacerda MVG; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.; Instituto Leônidas & Maria Deane, Fiocruz, Manaus, Brazil.
Printes VS; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.
Praia Marins AF; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.
Rebelo Rabelo AL; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Costa AA; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.
Tavares MA; Universidade Federal do Amazonas, Manaus, Brazil.
Jesus JS; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.
Souza AB; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Beraldi-Magalhães F; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Neves CP; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Monteiro WM; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Sampaio VS; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Amaral EP; Immunobiology Section, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Gomes RS; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Andrade BB; Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research, (MONSTER) Initiative, Salvador, Brazil.; Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências, Salvador, Brazil.; Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Brazil.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT), Cape Town, South Africa.; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Cordeiro-Santos M; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.; Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Jun 26; Vol. 15 (6), pp. e0235381. Date of Electronic Publication: 2020 Jun 26 (Print Publication: 2020).
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Hospitalization*
Safety*
Acetylcysteine/*adverse effects
Acetylcysteine/*therapeutic use
HIV Infections/*complications
Tuberculosis/*complications
Tuberculosis/*drug therapy
Adult ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies